Meningococcal Immunisation: Clinical Trials

1 trial for Meningococcal Immunisation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Meningococcal Immunisation: new trials by email Literature Review of Meningococcal Immunisation trials Research Report on Meningococcal Immunisation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
MenACYW conjugate vaccine - Meningococcal Immunisation, Healthy Volunteers
Phase 4CompletedSanofi Pasteur, a Sanofi Company712023-09-072025-09-22

Sponsors

Sanofi Pasteur, a Sanofi Company (1)

Countries

Argentina (1)

NIH funding

2025 (1)